Delivery Order 36C25721D0118-36C25721N0718
- Not listed
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The award is for the provision of ACCU-CHECK INFORM II METER, BASE UNIT LIGHT, ACCESSORIES, TEST STRIPS, CONTROL SOLUTION, LINEARITY KIT, PRO UNO LANCET, with a ceiling value of $14,916.44. The contract is a Purchase Order with a Firm Fixed Price pricing type, awarded by the Bureau of...
- This is a modification to exercise Option Year 4 of an Indefinite Delivery, Indefinite Quantity (IDIQ) contract between the Department of Veterans Affairs (VA) and Roche Diagnostics Corporation for the provision of ACCU-CHEK INFORM II test strips. The contract has a Period of Performance from September 15, 2025 to September 14, 2026 and a ceiling value of $23,328.00. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Roche Diagnostics...
- This is a $114,609.30 definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is for COAGUCHEK lancets and ACCU-CHEK INFORM test strips, with a completion date of May 3, 2024. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does not have a...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diabetes Care Inc. for $464,002.56 to provide ACCU CHEK AVIVA PLUS TEST STRIPS. The award is not set aside for any small business program. Roche Diabetes Care Inc. is a leading manufacturer of diabetes management products and is an experienced federal contractor, holding a General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics. Through this contract,...
- This federal contract award is for the delivery of GLUCOSE STRIPS to the Veterans Integrated Service Network 4, a civilian agency within the Department of Veterans Affairs. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, on September 1, 2024, with a ceiling value of $24,724.39 and an ultimate completion date of August 31, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. Roche Diagnostics...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $71,985.60 contract is for the ACCU-CHEK INFORM II system, which includes critical care analyzers, reagents, and test kits. It is not a set-aside contract. Roche Diagnostics has a long history of providing laboratory instrumentation, supplies, and services to various...
- This is a federal contract award from the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to Roche Diagnostics Corporation. The contract is for the provision of ACCU CHEK testing supplies, with a ceiling value of $16,347.06 and a period of performance ending on November 1, 2025. The contract was awarded on October 7, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Roche Diagnostics Corporation is a foreign-owned, for-profit...
- This is a federal contract award for glucose strips, awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract has a ceiling value of $23,328.00 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 31, 2026. Roche Diagnostics Corporation holds multiple significant Indefinite Delivery Contracts and Blanket...
- The Defense Health Agency awarded Roche Diagnostics Corporation a purchase order for Accu-Chek Inform II test strips and Accu-Check machines and supplies, with a ceiling value of $62,716. This firm fixed-price contract, effective through September 18, 2028, supports point-of-care glucose monitoring capabilities at Fort Belvoir, Virginia. The award carries no set-aside designation, reflecting open competition in the federal marketplace. Roche Diagnostics Corporation, a foreign-owned...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for ACCU CHEK products. The contract has a ceiling value of $34,428.24 and a period of performance through May 6, 2023. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does not have a set-aside designation....
- 36C25721D0118Indefinite Delivery Contract
- 36C25721D0118-36C25721N0718Delivery Order
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract is for the supply of ACCU-CHEK INFORM II test strips over a one-year base period from September 15, 2021 to September 14, 2022, with a potential completion date of September 14, 2026. The contract ceiling value is $138,348.00. Roche Diagnostics is an established federal contractor, holding multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across various government agencies for a range of medical diagnostic technologies and services. This contract award was not set aside for any small business category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($2k) | 7/17/25 | |
| P00001 | Exercise an Option | $23.3k | 8/25/22 | |
| Not listed | Not listed | $23.3k | 9/14/21 |